79 related articles for article (PubMed ID: 11892609)
21. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
Richardson D; Lamba H
Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
[TBL] [Abstract][Full Text] [Related]
22. Tenofovir: Gilead applies for approval; expanded access liberalized.
Gilden D
AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
[TBL] [Abstract][Full Text] [Related]
23. Tenofovir (viread) receives FDA approval.
AIDS Alert; 2002 Jan; 17(1):10-1. PubMed ID: 11862732
[No Abstract] [Full Text] [Related]
24. [Further indications for tenofovir].
Dtsch Med Wochenschr; 2003 Sep; 128(39):2037. PubMed ID: 14565207
[No Abstract] [Full Text] [Related]
25. Gilead sciences releases Viread.
Giles C
Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
[No Abstract] [Full Text] [Related]
26. Editorial comment: a tale of two viruses.
Dieterich DT
AIDS Read; 2002 Oct; 12(10):448-9. PubMed ID: 12408102
[No Abstract] [Full Text] [Related]
27. Tenofovir DF expanded access. Criteria for U.S. program.
AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
[TBL] [Abstract][Full Text] [Related]
28. Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report.
Alcaide ML; Kolber M; Jayaweera D
Int J STD AIDS; 2002 Nov; 13(11):795-6. PubMed ID: 12437905
[No Abstract] [Full Text] [Related]
29. Anti-HIV agents. Tenofovir looks good in initial therapy.
TreatmentUpdate; 2002 Aug; 14(6):3-5. PubMed ID: 12238450
[No Abstract] [Full Text] [Related]
30. Encouraging results for tenofovir.
AIDS Patient Care STDS; 2001 May; 15(5):289. PubMed ID: 11530770
[No Abstract] [Full Text] [Related]
31. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
32. New uses for tenofovir: more questions about d4T.
Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
[TBL] [Abstract][Full Text] [Related]
33. Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
AIDS Treat News; 2004 Mar; (399):5. PubMed ID: 15199867
[TBL] [Abstract][Full Text] [Related]
34. Tenofovir helps beat hepatitis B.
TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
[No Abstract] [Full Text] [Related]
35. Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Verhelst D; Monge M; Meynard JL; Fouqueray B; Mougenot B; Girard PM; Ronco P; Rossert J
Am J Kidney Dis; 2002 Dec; 40(6):1331-3. PubMed ID: 12460055
[TBL] [Abstract][Full Text] [Related]
36. [Nucleotide analog shows effectiveness in previously treated patients. The new kind of HAART].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():62-4. PubMed ID: 12043078
[No Abstract] [Full Text] [Related]
37. Expanded access.
Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
[TBL] [Abstract][Full Text] [Related]
38. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
39. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
40. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
